Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4 small nuclear 39, pseudogene (RNU4-39P) represents a **non-functional genomic sequence** derived from the U4 small nuclear RNA. It retains substantial sequence homology to the first 68 nucleotides of the human U4 snRNA but contains substitutions at two positions and is flanked by direct repeats, consistent with integration via reverse transcription[1]. Pseudogenes like RNU4-39P do not encode functional RNA and are not involved in spliceosome assembly or pre-mRNA splicing; instead, they are byproducts of genomic evolution and serve as evidence of past molecular events. No disease associations, drug interactions, or biomarker roles are currently documented. If your query requires information about an **active U4 small nuclear RNA gene or its role in splicing and disease**, you may want to refer to RNU4-2 or RNU4-1, which are functional snRNA genes participating in spliceosomal activity and have known clinical relevance[2][3]. If your intention was to investigate those molecules, please clarify your query.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 39, pseudogene (RNU4-39P).